BioPorto A/S
BIOPOR
Pozycja w akcjach
#22970
BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker... BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker tests, research tools, and antibodies to medical professionals and scientists worldwide, with operations across Europe, North America, and Asia. Among its offerings is the neutrophil gelatinase-associated lipocalin (NGAL) test, a precise quantitative particle-enhanced turbidimetric immunoassay designed for use on automated chemistry analyzers. The company further provides monoclonal antibodies essential for scientific, pharmaceutical, and clinical investigations. Additionally, BioPorto produces enzyme-linked immunosorbent assay (ELISA) kits and a versatile rapid assay device tailored for custom lateral flow assay development. Established in 1917, the company is headquartered in Hellerup, Denmark.
Cena akcji
$0.15400149
Kapitalizacja rynkowa
$76.25M
Zmiana (1 dzień)
-5.83%
Zmiana (1 rok)
-46.53%
Kraj
DK
Handel BioPorto A/S (BIOPOR)
Kategoria
Healthcare
Historia ceny akcji dla BioPorto A/S (BIOPOR)
Najwyższa cena zamknięcia: $0.15 dnia 2026-10-01
Najniższa cena zamknięcia: $0.41 dnia 2019-12-01
Najniższa cena zamknięcia: $0.41 dnia 2019-12-01
Historia cen akcji firmy BioPorto A/S od 2019 do 2026
Roczna wydajność ceny akcji
| Rok | Wydajność |
|---|---|
| 2026 (TTM) | -35.32% |
| 2025 | 0.00% |
| 2024 | -28.16% |
| 2023 | -37.74% |
| 2022 | -14.14% |
| 2021 | 106.94% |
| 2020 | -11.60% |
| 2019 | 0.00% |
Cena akcji podobnych firm lub konkurencji
| Firma | Cena akcji | Zmiana 1r% | Kraj |
|---|---|---|---|
| $694.53 | 24.47% |
US
|
|
| $234.00 | 5.99% |
US
|
|
| $416.01 | 122.61% |
US
|
|
| $22.06 | 54.01% |
CN
|
|
| $177.93 | 22.13% |
US
|
